丹參多酚酸B通過NLRP3/Caspase-1/GSDMD通路抑制OGD誘導(dǎo)海馬神經(jīng)元焦亡的分子機(jī)制研究
[關(guān)鍵詞]血管性癡呆;丹參多酚酸B;氧糖剝奪;細(xì)胞焦亡;NLRP3/Caspase-1/GSDMD信號通路;網(wǎng)絡(luò)藥理學(xué)[中圖分類號]R285.5 [文獻(xiàn)標(biāo)志碼]A [文章編號]doi:10.3969/j.issn.1674-070X.2025.04.008
[Abstract]Objective To explore thepotential molecular mechanisms of salvianolicacidB (Sal B)in treating vascular dementia(VD)throughnetworkpharmacologyandexperimentalverification.MethodsNetworkpharmacologywasusedto identifythepotentialargetsofalBinterventioninVD.Aprotein-proteininteraction(PP)networkwasonstructed,folloed by GO and KEGG pathwayenrichmentanalyses todetermine biologicallrelevant target pathways.Moleculardocking wasperfored toevaluate theinteractionbetweenSalBanditstargets.TheoptimalconcentrationofSalBwasdeterminedvia CCK-8assay thecellorphologywasobservedunderamicroscope,andthereleaserateoflactatedehydrogenase(LDH)inthecellsupeatant wasmeasuredusingamicroplatereader.The levelsof inflammatoryfactorsweremeasuredbyELISA,theproteinexpresionof NLRP3wasexaminedbyimmunofluorescence,andtheproteinexpresion levelsofNOD-likereceptorprotein3(NLRP3), apoptosis-assiatedspck-likeproteinontainingaD(ASC)cysteinylaspartatespecifcproteinase1(Caspase-1),ndD werecheckedbyWesternblot.ResultsAtotalof37targetsforSalBinterventioninVDwereobtainedbybioinformatics analysis.CoretargetgenessuchasCaspase-1,NLRP3,andTNFR1werescreenedbynetwork pharmacologyandthepathways including theNOD-likereceptors(NLRs)signaling pathwaythatmayinvolvethesetargetgeneswereidentifiedthrough KEGG andGOanalyses.InvitroexperimentswereperformedusingtheclassicNLRP3/Caspase-1/GSDMDpyroptosispathway.The OGD-inducedpyroptosismodelofhippocampalneuronswasestablished,anditwasfoundthatSalBcouldsignificantly enhance the survival rate of HT22 cells after OGD ( P<0.05 ,P<0.01),alleviate cell damage,reduce LDH release ( P<0.05 or P<0.01 ) decrease the levels of IL- 1β and IL-18 in OGD-damaged HT22 cells (P<0.01),inhibit theactivation of NLRP3 inflammasome,and reduce the protein expression levels of NLRP3, GSDMD-N, cleaved Caspase-1,and ASC( P <0.05,P
[Keywords]vascular dementia;salvianolicacid B; oxygen-glucose deprivation; pyroptosis;NLRP3/Caspase-1/GSDMD sig naling pathway; network pharmacology
血管性癡呆(vascular dementia,VD)是認(rèn)知功能下降的常見原因,是第二大常見的癡呆類型,約占全球癡呆病例的 20%[2] ,世界衛(wèi)生組織已將VD的防治列為21世紀(jì)重點(diǎn)科研項(xiàng)目之一[3-4]。(剩余14006字)
-
-
- 湖南中醫(yī)藥大學(xué)學(xué)報(bào)
- 2025年04期
- ·國醫(yī)大師·...
- 清心寧神湯對心不藏神不寐模型大...
- 基于 JAK-STAT/NF-...
- 基于TGF-β1/Smad信號...
- 中等強(qiáng)度耐力運(yùn)動對老年性骨質(zhì)疏...
- 白果內(nèi)酯改善環(huán)磷酰胺所致小鼠免...
- 地黃苷A對成骨細(xì)胞增殖分化及M...
- 丹參多酚酸B通過NLRP3/C...
- 去甲烏藥堿配伍6-姜酚前后對衰...
- 厚樸飲片質(zhì)量等級標(biāo)準(zhǔn)綜合評分機(jī)...
- 單質(zhì)硫催化查爾酮類化合物選擇性...
- 芒針針刺次穴聯(lián)合常規(guī)針刺治療不...
- 刮痧聯(lián)合四海之腧取穴針刺法治療...
- 基于“陽化氣,陰成形"...
- 清熱潤目湯霧化熏蒸聯(lián)合玻璃酸鈉...
- 病證結(jié)合診治下脂肪墊增生綜合征...
- 教授基于“陽主陰從"...
- 教授基于“痞堅(jiān)之處,必有伏陽”...
- 基于多元統(tǒng)計(jì)分析和貝葉斯網(wǎng)絡(luò)的...
- 基于“玄府-氣血-絡(luò)脈&quo...
- 基于相火學(xué)說淺析玫瑰痤瘡證治...
- 基于“一氣周流"理論...
- 基于絡(luò)病理論從“通補(bǔ)腦絡(luò)&qu...
- 從《醫(yī)旨緒余》“種子之道&qu...
- 從“脾失散精、毒邪內(nèi)生&quo...
- 從“虛損生積”論治肝纖維化...
- 歷史文化遺產(chǎn)視角下馬王堆醫(yī)學(xué)文...
- 簡帛醫(yī)藥文獻(xiàn)藥物研究現(xiàn)狀與展望...
- ‘三明治"教學(xué)體系在...
- 中醫(yī)藥文化融入港澳臺大學(xué)生思政...